PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+Lispro
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
Whether a once-daily basal injection of insulin glargine with mealtime injections of insulin
lispro achieves equivalent glycaemic control (HbA1c) to administration of insulin lispro by
continuous subcutaneous insulin infusion in Type 1 diabetic patients.